ANXA5 and breast carcinoma: As expected, both the Annexin V assay (Figs. 6F and S2G) and the TUNEL assay (Figs. 6G and S2H) confirmed that simultaneous administration of FGF21 effectively mitigated DOX-induced breast cancer cell apoptosis.